COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

The PDA (Pharmacists’ Defence Association)

The PDA is a not-for-profit organisation which supports the needs of individual employed and locum pharmacists and pharmacy students and, when necessary, defends their reputation. With more than 37,000 members we are the largest pharmacist membership organisation and the only independent trade union exclusively for pharmacists in the UK.

  • 37000+PDA Members
  • 1278Active Cases
  • 1365Membership Queries

Join The PDA Today Renew Your Membership

Track an existing application

COVID-19 VACCINATIONS:
If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

  • Read More Latest Policy Documents

    • Scotland Covid-19 Inquiry: My day in court for the PDA

      Thu 7th November 2024 The PDA

      Earlier this year, PDA Head of Policy for Scotland, Maurice Hickey spoke at the Scottish Covid-19 Inquiry to share the experiences of working pharmacists during the pandemic. Here, he discusses his impact report and why he felt it was so important to speak at the inquiry. 

    • PDA issues advisory information on the legal dispensing of methadone via instalment prescriptions

      Wed 28th August 2024 The PDA

      A recent Coroner's Prevention of Future Deaths report has highlighted the actions of a responsible pharmacist as being a contributory factor to a patient's death. Their actions did not comply with controlled drug legislation. In response to this, the PDA is issuing an advisory note on the legal dispensing of methadone via instalment prescriptions. 

    • PDA publishes summary of the Pharmacy Technicians Report

      Sun 5th May 2024 The PDA

      The PDA has launched its summary of the PDA Pharmacy Technicians Report for members. The summary outlines the key points and recommendations made in 2019. 

  • Read More Latest Resources

    • Intersection Update – November 2024

      Thu 28th November 2024 The PDA

      Intersection is the PDA's newsletter bringing together news from all four PDA Equality, Diversity, and Inclusion (EDI) Networks. We encourage all PDA members to get involved in the networks that are of interest to them. 

    • Insight Online – November 2024

      Wed 27th November 2024 The PDA

      This month, read about the government's consultation that aims to shape a 10-year health plan for the NHS in England. Also, read our response to the GPhC's consultation on changes to the ‘guidance for registered pharmacies providing pharmacy services at a distance, including on the internet’. Plus, access FREE PDA resources designed to keep you safe at work.  

    • Insight Online – October 2024

      Wed 30th October 2024 The PDA

      This month, read about the publication of the Employment Rights Bill along with some of the proposed changes to online prescribing through the GPhC's consultation. You can also access FREE PDA Equality, Diversity, and Inclusion resources and have your say on upcoming training opportunities provided through PDA Education.  

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)